相关实验视频

Updated: Jan 7, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

全基因组的CRISPR屏幕显示了一种非特征化的spliceosome调节器,作为新的候选免疫治疗点

Tong Shao¹, Chuanyang Liu¹, Jingyu Kuang¹

¹College of Science National University of Defense Technology Changsha China.

|December 31, 2025

概括

我们发现了C9ORF50,一种新的拼接调节器,可以控制癌症的免疫逃避. 抑制C9ORF50增强了抗瘤免疫力和T细胞透,为癌症免疫治疗提供了一个新的治疗策略.

科学领域:

癌症生物学癌症生物学
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

癌症免疫逃避是一个复杂的过程,由瘤内在因素驱动.
免疫规避的关键分子调节者仍未完全定义.
了解这些调节剂对于开发有效的癌症免疫疗法至关重要.

研究的目的:

确定癌细胞中免疫逃避的新型基因调节决定因素.
研究C9ORF50在调节癌症免疫力中的作用.
探索C9ORF50作为增强免疫疗法的潜在治疗点.

主要方法:

在体内进行了全基因组的CRISPR功能丧失屏幕.
使用集成的多omics分析分析分析C9ORF50函数.
评估C9ORF50抑制对瘤免疫性和T细胞透的影响.

主要成果:

确定C9ORF50是一种新型拼接调节剂,当被抑制时,使癌症对免疫监测敏感.
C9ORF50形成涉及拼接的核凝聚物,其切除导致内质保留和细胞质双链RNA积累.
抑制C9ORF50增强了I型干扰素的激活,增加了化学因子介导的T细胞的招募,并改善了T细胞透在透不良的瘤.
较高的C9ORF50表达与患者的生存率差以及各种癌症中淋巴细胞透率降低有关.

结论:

C9ORF50是RNA剪接和瘤免疫力的关键调节者.
向C9ORF50可以增强癌症免疫性和T细胞透,抑制瘤生长.
拼接调节是改善癌症患者免疫治疗反应的有希望的策略.

关键词:

在C9ORF50中,C9ORF50是什么?C9ORF50是什么?这是一个CRISPR屏幕.通过RNA拼接进行RNA拼接.抗瘤免疫力免疫力本质上是无序的蛋白质.液体液体相分离器液体相分离器治疗目标是治疗的目标.

更多相关视频

Performing an In Vitro Genome-Wide CRISPR Knockout Screen in Chimeric Antigen Receptor T Cells

Performing an In Vitro Genome-Wide CRISPR Knockout Screen in Chimeric Antigen Receptor T Cells

Published on: January 31, 2025

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Published on: September 4, 2019

相关概念视频

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...